Article
Reversing chemorefraction in colorectal cancer cells by controlling mucin secretion
7 Feb 2022
Abstract excerpt
Fifteen percent of colorectal cancer (CRC) cells exhibit a mucin hypersecretory phenotype, which is suggested to provide resistance to immune surveillance and chemotherapy. We now formally show that CRC cells build a barrier to chemotherapeutics by increasing mucins' secretion. We show that low levels of KChIP3, a negative regulator of mucin secretion (Cantero-Recasens et al., 2018), is a risk factor for CRC...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
